The data was published in November issue of the Journal of Sexual Medicine.
Testim is a clear topical gel containing 1% testosterone, used to treat adult males who have low or no testosterone.
Investigators assessed data from 271 TRiUS patients and evaluated the correlation between changes in the patients’ Brief Male Sexual Function Inventory (BMSFI) scores and their mean total testosterone levels after 12 months of Testim therapy.
Regression analysis showed that the increased total BMSFI score was associated with increased total testosterone levels.
Â